Medicine and Dentistry
Dyspnea
100%
Randomized Controlled Trial
60%
Placebo
40%
Quality of Life
32%
Chronic Obstructive Pulmonary Disease
27%
Arm
25%
End of Life Care
20%
Xerostomia
20%
General Practitioner
20%
Thirst
20%
Amyotrophic Lateral Sclerosis
20%
Academic Detailing
20%
Fumaric Acid Dimethyl Ester
20%
Home Oxygen Therapy
20%
Motor Neuron Disease
20%
Oscillometry
20%
Cancer Pain
20%
Histamine
20%
Bowel Obstruction
20%
Octreotide
20%
Endorphin
20%
Pregabalin
20%
Exhalation
20%
Symptomatic Treatment
16%
Opioid Receptor
16%
Diseases
14%
17 Methylnaltrexone
13%
Noninvasive Ventilation
13%
Spirometry
11%
Exercise
10%
Naloxone
10%
Advanced Cancer
9%
Patient with Asthma
8%
Clinician
8%
Low Drug Dose
7%
Morphine
6%
Side Effect
6%
Outpatient
6%
Brief Pain Inventory
5%
Chemotherapy-Induced Peripheral Neuropathy
5%
Table Salt
5%
Malignant Neoplasm
5%
Care Group
5%
Pharmacological Treatment
5%
Rating Scale
5%
Nursing and Health Professions
Palliative Therapy
88%
Xerostomia
60%
Terminal Care
42%
Placebo
22%
Medical Student
20%
Oscillometry
20%
Histamine
20%
Pulse Oximetry
20%
Octreotide
20%
Physician
20%
Health Care Personnel
20%
Nerve Block
20%
Home Oxygen Therapy
20%
Motor Neuron Disease
20%
Quality of Life
20%
Intestine Obstruction
20%
Medical Staff
20%
Shoulder Pain
20%
Dyspnea
20%
Syndrome
20%
Diseases
18%
Practice Guideline
10%
Care Pathway
10%
Occupational Therapist
10%
Clinical Assessment
10%
Registered Nurse
10%
Clinical Guideline
10%
Health Practitioner
10%
Intensive Care Unit
8%
Patient with Asthma
8%
Spirometry
8%
Self Care
8%
Base
6%
Patient Population
6%
Nursing Staff
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
45%
Dyspnea
40%
Placebo
40%
Chronic Obstructive Lung Disease
25%
Octreotide
20%
Intestine Obstruction
20%
Shoulder Pain
20%
Amyotrophic Lateral Sclerosis
20%
Motor Neuron Disease
20%
Pharmacovigilance
20%
Fumaric Acid Dimethyl Ester
20%
Endorphin
20%
Essential Drug
20%
Sustained Release
20%
Morphine
20%
Opiate Receptor
16%
Methylnaltrexone
13%
Naloxone
10%
Side Effect
10%
Table Salt
5%
Constipation
5%
Phase IV
5%
Observational Study
5%
Number Needed to Treat
5%
Laxative
5%